🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
TQB3616 capsule is a small molecule oral drug developed by Chia Tai Tianqin...
Status
Completed
Location
Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Start Date
2021-07-06
Trial ID
NCT05344729
Treatments Being Tested
To evaluate the effect of itraconazole/rifampicin on the pharmacokinetics o...
Status
Not Yet Recruiting
Location
Beijing Tongren Hospital Affiliated to Capital Medical University
Start Date
2024-11
Trial ID
NCT06662773
Treatments Being Tested
A clinical trial evaluating TQB3616 capsules versus placebo in the treatmen...
Status
Terminated
Location
Peking University First Hospital
Start Date
2022-08-08
Trial ID
NCT05496569
Treatments Being Tested
This is an open, multi-cohort, exploratory phase II study on the safety and...
Status
Terminated
Location
Chongqing University Cancer Hospital
Start Date
2021-08-18
Trial ID
NCT04924192
Treatments Being Tested
This trial was designed to evaluate the maximum tolerated dose (MTD) and ph...
Status
Terminated
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2025-05-16
Trial ID
NCT06851442
Treatments Being Tested
This is a Phase III, randomized, double-blind, parallel, multi-center trail...
Status
Active Not Recruiting
Location
Cancer Hospital Chinese Academy of Medical Science
Start Date
2023-03-30
Trial ID
NCT05780567
This is a phase Ib/II exploratory study. Phase Ib includes the dose escalat...
Status
Recruiting
Location
Affiliated Cancer Hospital of Chongqing University
Start Date
2023-04-13
Trial ID
NCT06202261
This study is a multicenter, open-label, multi-cohort phase II clinical tri...
Status
Completed
Location
The Fifth Medical Center of PLA General Hospital
Start Date
2021-02-04
Trial ID
NCT04796623
Treatments Being Tested
A randomized, double-blind, parallel-controlled, multicenter trial design w...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2022-07-01
Trial ID
NCT05365178
Treatments Being Tested
This is a Phase III, a randomized, double-blind, parallel , multi-center tr...
Status
Completed
Location
The Fifth Medical Center of PLA General Hospital
Start Date
2022-03-18
Trial ID
NCT05375461
Treatments Being Tested